PacBio reports a deepening of its AI drug‑discovery push, announcing expanded collaboration between its long‑read sequencing technology and advanced machine‑learning

C&EN highlights the July 17, 2026 feature titled “How AI Is Taking Over Every Step of Drug Discovery,” which outlines that machine‑learning models are now being applied from early target identification through to final candidate selection, signaling a broad workflow transformation.

PacBio reports a deepening of its AI drug‑discovery push, announcing expanded collaboration between its long‑read sequencing technology and advanced machine‑learning pipelines to accelerate compound screening and improve predictive accuracy.

ZS Research releases a study titled “After Years of Hype, AI Value Is Finally Emerging in Pharma,” which shows that pharmaceutical firms are beginning to record measurable financial returns from AI tools, moving the technology beyond speculative hype.

Drug Discovery News tracks the sector‑wide AI integration trend, noting that multiple companies are adopting similar machine‑learning strategies to shorten research timelines and increase the efficiency of drug development pipelines.